 |
 |

Proton Magnetic Resonance Spectroscopic Imaging of Cortical Gray and White Matter in Schizophrenia
Kelvin O. Lim, MD;
Elfar Adalsteinsson, PhD;
Daniel Spielman, PhD;
Edith V. Sullivan, PhD;
Margaret J. Rosenbloom, MA;
Adolf Pfefferbaum, MD
Arch Gen Psychiatry. 1998;55:346-352.
Objective To apply in vivo proton magnetic resonance spectroscopy imaging estimates of N-acetylaspartate (NAA), a neuronal marker, to clarify the relative contribution of neuronal and glial changes to the widespread volume deficit of cortical gray matter seen in patients with schizophrenia with magnetic resonance images.
Methods Ten male veterans meeting criteria of the DSM-IV, for schizophrenia and 9 healthy age-matched men for comparison were scanned using spectroscopic, anatomical, and field-map sequences. Instrument and collection variables were standardized to allow an estimation of comparable values for NAA, choline, and creatine for all subjects. Metabolite values from each voxel on 3 upper cortical slices were regressed against the gray tissue proportion of that voxel to derive estimates of gray and white matter NAA, creatine, and choline concentrations.
Results The volume of cortical gray matter was reduced in patients with schizophrenia, but NAA signal intensity from a comparable region was normal. In contrast, the volume of cortical white matter was normal in patients with schizophrenia, but NAA signal intensity from a comparable region was reduced.
Conclusions The lack of reduction in gray matter NAA signal intensity suggests that the cortical gray matter deficit in these patients involved both neuronal and glial compartments rather than a neurodegenerative process in which there is a decrease in the neuronal relative to the glial compartment. Reduced white matter NAA signal intensity without a white matter volume deficit may reflect abnormal axonal connections.
From the Psychiatry Service, Veterans Affairs Palo Alto Health Care System, Palo Alto (Dr Lim); the Department of Psychiatry and Behavioral Sciences (Drs Lim, Sullivan, and Pfefferbaum and Ms Rosenbloom) and the Department of Diagnostic Radiology (Drs Adalsteinsson and Spielman), Stanford University School of Medicine, Stanford; and the Neuropsychiatry Program, SRI International, Menlo Park (Drs Sullivan and Pfefferbaum), Calif. Dr Lim is now with the Division of Medical Physics, Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY.
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Global White Matter Abnormalities in Schizophrenia: A Multisite Diffusion Tensor Imaging Study
White et al.
Schizophr Bull 2009;0:sbp088v2-sbp088.
ABSTRACT
| FULL TEXT
Connections in Schizophrenia
Lim
Am. J. Psychiatry 2007;164:995-998.
FULL TEXT
Deconstructing Psychosis With Human Brain Imaging
Gur et al.
Schizophr Bull 2007;33:921-931.
ABSTRACT
| FULL TEXT
Methamphetamine Users in Sustained Abstinence: A Proton Magnetic Resonance Spectroscopy Study
Nordahl et al.
Arch Gen Psychiatry 2005;62:444-452.
ABSTRACT
| FULL TEXT
White Matter Changes in Schizophrenia: Evidence for Myelin-Related Dysfunction
Davis et al.
Arch Gen Psychiatry 2003;60:443-456.
ABSTRACT
| FULL TEXT
Working Memory Deficits and Levels of N-Acetylaspartate in Patients With Schizophreniform Disorder
Bertolino et al.
Am. J. Psychiatry 2003;160:483-489.
ABSTRACT
| FULL TEXT
Compounded Brain Volume Deficits in Schizophrenia-Alcoholism Comorbidity
Mathalon et al.
Arch Gen Psychiatry 2003;60:245-252.
ABSTRACT
| FULL TEXT
Magnetic resonance spectroscopy and cognitive function in healthy elderly men
Ferguson et al.
Brain 2002;125:2743-2749.
ABSTRACT
| FULL TEXT
Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging
Foong et al.
Brain 2001;124:882-892.
ABSTRACT
| FULL TEXT
Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia
Hakak et al.
Proc. Natl. Acad. Sci. USA 2001;98:4746-4751.
ABSTRACT
| FULL TEXT
Progressive Brain Volume Changes and the Clinical Course of Schizophrenia in Men: A Longitudinal Magnetic Resonance Imaging Study
Mathalon et al.
Arch Gen Psychiatry 2001;58:148-157.
ABSTRACT
| FULL TEXT
Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers: Implications for Models of Cognitive Deficits in Schizophrenia
Umbricht et al.
Arch Gen Psychiatry 2000;57:1139-1147.
ABSTRACT
| FULL TEXT
Volumetric Measure of the Frontal and Temporal Lobe Regions in Schizophrenia: Relationship to Negative Symptoms
Sanfilipo et al.
Arch Gen Psychiatry 2000;57:471-480.
ABSTRACT
| FULL TEXT
Proton Magnetic Resonance Spectroscopy of the Medial Prefrontal Cortex in Patients With Deficit Schizophrenia: Preliminary Report
Delamillieure et al.
Am. J. Psychiatry 2000;157:641-643.
ABSTRACT
| FULL TEXT
Magnetic resonance spectroscopy: Bridging the neurochemistry and neuroanatomy of schizophrenia
BUCKLEY and FRIEDMAN
Br. J. Psychiatry 2000;176:203-205.
FULL TEXT
In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging
Foong et al.
J. Neurol. Neurosurg. Psychiatry 2000;68:70-74.
ABSTRACT
| FULL TEXT
Compromised White Matter Tract Integrity in Schizophrenia Inferred From Diffusion Tensor Imaging
Lim et al.
Arch Gen Psychiatry 1999;56:367-374.
ABSTRACT
| FULL TEXT
|